UK blood donation ban highlights TSE (transmissible spongiform encephalopathy) test needs
This article was originally published in Clinica
The need for an in vivo test for variant Creutzfeldt-Jakob disease has gained new urgency in the UK, after the government announced last week restrictions on blood donation. In light of an "uncertain but slight risk" of transmissible exposure to vCJD, people who received a blood transfusion since 1980 are banned from donating blood.
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.